Related Experiment Videos

Soluble Fas/APO-1 in tumor cells: a potential regulator of apoptosis?

L B Owen-Schaub1, L S Angelo, R Radinsky

  • 1Department of Immunology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

Cancer Letters
|July 20, 1995
PubMed

Insights

Researchers found a mutant Fas/APO-1 gene in osteosarcoma cells resistant to apoptosis. This mutant Fas/APO-1 gene produces a soluble protein, potentially impacting cancer development.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Fas/APO-1 receptor mediates apoptosis, a crucial process for cell death.
  • Dysregulation of apoptosis is implicated in cancer development and treatment resistance.

Purpose of the Study:

  • Investigate Fas/APO-1 gene defects in an osteosarcoma cell line resistant to anti-Fas induced apoptosis.
  • Characterize the molecular basis of resistance to Fas/APO-1 mediated cell death.

Main Methods:

  • cDNA cloning and sequencing to identify gene mutations.
  • Immunoprecipitation and Western blotting to detect protein expression.

Main Results:

  • Identified both authentic and a mutant Fas/APO-1 gene (DFas/APO-1) with a deletion in the transmembrane domain.
  • Confirmed the presence of a soluble Fas/APO-1 protein in the resistant cells.

Conclusions:

  • A soluble Fas/APO-1 protein, resulting from a gene defect, may contribute to resistance against apoptosis.
  • The production of soluble Fas/APO-1 has potential implications in the pathogenesis of malignant diseases.

Related Concept Videos